We value working in partnerships and collaborating - leveraging the expertise of others in their respective fields to achieve our mission.
GSK has been a significant supporter of The George Institute for Global Health for a number of years and we’ve recently contributed $161,000 to support a research fellow in respiratory medicine.
The fellowship aims to provide the research fellow with an opportunity to further develop their skills and expertise in implementation, conception and design of multicentre respiratory clinical, epidemiological or public health studies in the Asia Pacific Region.
The fellowship will also enable further fostering of excellence in respiratory research focused on achieving affordable and accessible health care for people in low and middle income countries, especially in this region.
Executive Director of The George Institute Australia, Professor Vlado Perkovic commented on what this means for the future of translational medicine:
"It is vital that we invest in the talented individuals who will shape the future of Australian healthcare. The GSK Respiratory Fellowship will ensure that we can support an exceptional researcher to focus on one of Australia’s most urgent health needs. We thank GSK for helping us to support Australia’s brightest young minds."
Professor Christine Jenkins, Head of Respiratory Trials at The George Institute, discussed how the fellowship will allow the candidate to develop their career in respiratory medicine:
"The GSK Respiratory Fellowship provides a research fellow with an excellent opportunity to train further and gain greater skills in measuring and understanding effective interventions to improve lung health, especially in the Asia Pacific region. At the same time the successful candidate will access the wonderful training opportunity that an organisation like The George Institute provides."